Tianda Pharmaceuticals Limited
Tianda Pharmaceuticals Limited (HKSE: 455) is trading at HK$0.12, about ₹1 at today's HKD/INR rate, as of 23 Sep 2026, 3:47 AM ET, down 0.82% today. Indian residents can buy Tianda Pharmaceuticals from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$0.11
Today's high
HK$0.13
52 week low
HK$0.08
52 week high
HK$0.17
455 opened at HK$0.13, closed previously at HK$0.12, and has traded between HK$0.08 and HK$0.17 over the past 52 weeks.
About
Founded in 1992 and headquartered in Central, Hong Kong, Tianda Pharmaceuticals Limited operates as an investment holding company and a subsidiary of Tianda Group Limited. The firm, which changed its name from Tianda Holdings Limited in September 2012, focuses on the research, development, manufacturing, and distribution of a wide array of pharmaceutical, biotechnology, and healthcare products. Its commercial reach extends across Mainland China, Hong Kong, and Australia. The company's diverse portfolio includes traditional Chinese medicines, chemical drugs, biological products, and medical appliances. These offerings target numerous therapeutic areas, such as cardio-cerebrovascular health, pediatric care, anti-flu and respiratory conditions, anti-infection, detoxification, and urological disorders. Health supplements are specifically marketed under the "Herb Valley" and "Tuokang" brand names. Furthermore, Tianda Pharmaceuticals is involved in the wholesale and retail of Chinese herbal medicines, traditional Chinese medicine (TCM) decoction pieces, and other Chinese medicinal products, provides Chinese medical services, and trades agricultural by-products.
Key statistics
Avg. volume
105.40K
Market cap
HK$260.16M
P/E Ratio
-7.08
Price-to-sales ratio
1.40
Enterprise value
HK$328.01M
Free cash flow yield
-4.84%
Debt-to-equity ratio
0.29
Return on equity
-8.05%
ROIC
-3.42%
Beta
-0.06
Dividend yield
0.00%
Last dividend
HK$0.00
Financial overview
Revenue
HK$322.94M
Earnings per share
-HK$0.03
Free cash flow
HK$2.80M
Net profit margin
-19.73%
Gross margin
41.18%
EBITDA
-HK$24.41M
Revenue growth
-2.12%
Similar securities
This is not an investment recommendation
How to buy Tianda Pharmaceuticals from India
Indian residents can buy Tianda Pharmaceuticals shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for Tianda Pharmaceuticals and place an order
Find Tianda Pharmaceuticals by name or by its ticker, 455, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Tianda Pharmaceuticals trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Tianda Pharmaceuticals position in HKD and INR. Tianda Pharmaceuticals pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Tianda Pharmaceuticals from India
Trading and taxes when buying Tianda Pharmaceuticals from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneTianda Pharmaceuticals does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- Estate or inheritance tax
- May applyHong Kong has no estate duty.Estate tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Tianda Pharmaceuticals stock?
Yes. Tianda Pharmaceuticals (455) has been listed on the Hong Kong Stock Exchange since 1992, in the Drug Manufacturers - Specialty & Generic industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Tianda Pharmaceuticals share cost in rupees?
One Tianda Pharmaceuticals share is HK$0.12 — about ₹1 at an HKD/INR rate of 12.23 on 26 Sep 2026. Both the Tianda Pharmaceuticals price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Tianda Pharmaceuticals from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Tianda Pharmaceuticals?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on Tianda Pharmaceuticals shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Tianda Pharmaceuticals price. Paasa issues a capital-gains statement for your return.
Does Tianda Pharmaceuticals pay a dividend?
No. Tianda Pharmaceuticals does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Tianda Pharmaceuticals from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is there estate or inheritance tax on Tianda Pharmaceuticals shares held from India?
Hong Kong has no estate duty.
Do I have to declare Tianda Pharmaceuticals shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Tianda Pharmaceuticals holding, its cost and its closing value.
How do I sell Tianda Pharmaceuticals and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.